MINNEAPOLIS, July 18, 2012 /PRNewswire/ --Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback